NMPA Approval

Metformin Hydrochloride and Glibenclamide Capsules(Ⅰ)

Approval Number

国药准字H20080346

Company吉林万通药业集团郑州万通复升药业股份有限公司

Registration Date

March 15, 2023

Drug Information

Generic Name

二甲双胍格列本脲胶囊(Ⅰ)

Brand Name

万通

Dosage Form

胶囊剂

Strength

每粒含盐酸二甲双胍250mg与格列本脲1.25mg

Drug Type

化学药品

Registration Date

March 15, 2023

Company Information

Applicant Company

Company Name吉林万通药业集团郑州万通复升药业股份有限公司

Company Address

郑州高新区冬青街34号

Manufacturing Company

Company Name吉林万通药业集团郑州万通复升药业股份有限公司

Company Address

郑州高新区冬青街34号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

二甲双胍格列本脲胶囊(Ⅰ) - NMPA 批准文号 | MedPath